Status:

COMPLETED

Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery

Lead Sponsor:

University of Utah

Conditions:

Thromboembolism

Postpartum DVT

Eligibility:

FEMALE

18-55 years

Phase:

NA

Brief Summary

The aim of this study is to evaluate the efficacy of two dosing regimens of low molecular weight heparin (LMWH) to reach prophylactic anti-factor Xa levels in post-cesarean delivery women. Half of par...

Detailed Description

Venous thromboembolism (VTE) is a major contributor to maternal morbidity and mortality. The immediate postpartum period is a high risk time for VTE, and cesarean delivery is an additional risk factor...

Eligibility Criteria

Inclusion

  • Cesarean delivery
  • Meet facility guidelines for postpartum venous thromboembolism (VTE) prophylaxis: Presence of 1 major, or 2 or more moderate, risk factors.
  • Major risk factors: history of venous thromboembolism, high risk thrombophilia, BMI ≥40, high risk medical comorbidities (heart disease, sickle cell disease, systemic lupus erythematosus, inflammatory bowel disease), cesarean hysterectomy, nephrotic range proteinuria, or cesarean intrapartum/during labor
  • Moderate risk factors: BMI \> 30, multifetal pregnancy, postpartum hemorrhage (\>1L blood loss), tobacco use, non-laboring or elective cesarean, preeclampsia, infection, preterm delivery (\< 37 weeks gestational age), age \> 35 years, low risk thrombophilia, family history of venous thromboembolism, stillbirth, varicose veins, prolonged labor (\> 24 hours)

Exclusion

  • Contraindication to anticoagulation
  • Plan for therapeutic anticoagulation (antepartum or postpartum)
  • Known renal dysfunction (Creatinine clearance \< 30 mL/minute)

Key Trial Info

Start Date :

June 12 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 15 2021

Estimated Enrollment :

146 Patients enrolled

Trial Details

Trial ID

NCT04305756

Start Date

June 12 2020

End Date

December 15 2021

Last Update

January 28 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Utah

Salt Lake City, Utah, United States, 84132